WATSON 349 (Acetaminophen and Hydrocodone 500 mg / 5 mg)
Pill imprint WATSON 349 has been identified as Acetaminophen and hydrocodone bitartrate 500 mg / 5 mg.
Acetaminophen/hydrocodone is used in the treatment of back pain; pain; rheumatoid arthritis; cough and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Acetaminophen/hydrocodone 500 mg / 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
- WATSON 349
- 500 mg / 5 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Narcotic analgesic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
|NDC Code||Manufacturer / Repackager|
|51079-0420||UDL Laboratories Inc|
|62584-0738||Amerisource Health Services|
|10544-0409||Blenheim Pharmacal Inc (repackager)|
|54868-0071||Physicians Total Care Inc (repackager)|
|68071-0659||Nucare Pharmaceuticals Inc (repackager)|
|21695-0269||Rebel Distributors Corp (repackager)|
|57866-3914||Direct Dispensing Inc (repackager)|
|66267-0109||Nucare Pharmaceuticals Inc (repackager)|
|63874-0203||Altura Pharmaceuticals Inc (repackager)|
|55887-0952||Diversified Healthcare Services Inc (repackager)|
|68115-0171||Dispensexpress Inc (repackager)|
|67544-0279||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
More about acetaminophen/hydrocodone
- Acetaminophen and Hydrocodone
- Acetaminophen/hydrocodone capsules
- Acetaminophen/hydrocodone liquid
- Hydrocodone/acetaminophen liquid
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.